Marker Therapeutics Inc MRKR:NASDAQ

Last Price$0.35NASDAQ Closing Price as of 4:00PM ET 7/01/22

Today's Change+0.02(4.85%)
Bid (Size)$0.35 (30)
Ask (Size)$0.35 (2)
Day Low / High$0.33 - 0.39
Volume416.2 K
 

View Biotechnology IndustryPeer Comparison as of 07/01/2022

 

Marker Therapeutics Inc ( NASDAQ )

Price: $0.35
Change: +0.02 (4.85%)
Volume: 416.2 K
4:00PM ET 7/01/2022
 
 

T2 Biosystems Inc ( NASDAQ )

Price: $0.17
Change: +0.009 (5.26%)
Volume: 2.9 M
4:00PM ET 7/01/2022
 
 

Bio Path Holdings Inc ( NASDAQ )

Price: $3.99
Change: +0.12 (3.10%)
Volume: 19.3 K
4:00PM ET 7/01/2022
 
 

India Globalization Capital Inc ( NYSE MKT LLC )

Price: $0.51
Change: -0.02 (3.77%)
Volume: 221.0 K
8:00PM ET 7/01/2022
 
 

Aravive Inc ( NASDAQ )

Price: $0.93
Change: -0.05 (5.46%)
Volume: 100.9 K
4:00PM ET 7/01/2022
 

Read more news Recent News

Piper Sandler Adjusts Marker Therapeutics' Price Target to $1.50 From $3.50, Reiterates Overweight Rating
5:13AM ET 5/31/2022 MT Newswires

Marker Therapeutics (MRKR) has an average rating of outperform and price targets ranging from $1 to $5, according to analysts polled by Capital IQ. (MT...

-- Earnings Flash (MRKR) MARKER THERAPEUTICS Posts Q1 Revenue $964,322
7:00AM ET 5/13/2022 MT Newswires

...

Marker Therapeutics Enters Services Agreement With Wilson Wolf; Shares Surge Pre-Bell
8:00AM ET 4/26/2022 MT Newswires

Marker Therapeutics (MRKR) said Tuesday that it entered into a deal to provide manufacturing services to Wilson Wolf Manufacturing Corporation. Shares of...

--Oppenheimer Adjusts Marker Therapeutics' Price Target to $5 From $8, Maintains Outperform Rating
10:04AM ET 2/17/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

View all Commentary and Analysis

AlloVir: A Comparative Study Of Its Manufacturing Process
9:52AM ET 2/07/2022 Seeking Alpha

Marker Therapeutics: Passing Through A Catalyst Desert
8:00AM ET 10/22/2021 Seeking Alpha

Company Profile

Business DescriptionMarker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX. View company web site for more details
Address3200 Southwest Freeway
Houston, Texas 77027
Phone+1.713.400.6400
Number of Employees11
President, Chief Executive Officer & DirectorPeter L. Hoang
Director, Chief Operating & Scientific OfficerJuan F. Vera
Chief Financial OfficerAnthony H. Kim
Vice President-Research & DevelopmentTsvetelina Pencheva Hoang

Company Highlights

Price Open$0.34
Previous Close$0.33
52 Week Range$0.25 - 2.97
Market Capitalization$28.9 M
Shares Outstanding83.6 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/09/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.51
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit Margin-1,949.65%
Return on Equity-88.13%

Analyst Ratings as of 02/15/2022

Buy
3
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset